Management of pain with diclofenac after femtosecond-assisted laser in situ keratomileusis
Authors:
- Amit TandonATAmit Tandon
- Roni M. ShteinRSRoni M. Shtein
- Kaz H. SoongKSKaz H. Soong
- Theresa N. CooneyTCTheresa N. Cooney
- David C. MuschDMDavid C. Musch
- Shahzad I. MianSMShahzad I. Mian
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 37 (3) , 569-573
Abstract
To evaluate the safety and efficacy of topical diclofenac sodium 0.1% after femtosecond laser-assisted laser in situ keratomileusis (LASIK). W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA. Clinical trial. Pain was assessed in patients treated with topical diclofenac sodium 0.1% or artificial tears immediately after LASIK using a numeric pain scale and a combined picture-numeric pain scale 0, 2, 4, 12, and 24 hours postoperatively. Visual outcomes and complications were noted up to 24 hours. The study enrolled 100 eyes of 50 patients. Patients treated with diclofenac 0.1% reported less pain than the control group on both pain scales 2, 4, 12, and 24 hours after surgery, with the maximum benefit at 4 hours (P=.02). Fewer patients in the diclofenac group (76.0%) than in the control group (91.3%) used oral pain and/or anxiolytic medications during the first 24 hours after surgery (P=.25). Ninety-eight eyes had an uncorrected distance visual acuity of 20/40 or better. Mild peripheral diffuse lamellar keratitis accounted for the majority of perioperative complications (n = 15). Pain after femtosecond laser-assisted LASIK was mild and was reduced with a single dose of topical diclofenac sodium 0.1% given immediately after surgery.Keywords
This publication has 18 references indexed in Scilit:
- Incidence of diffuse lamellar keratitis after laser in situ keratomileusis associated with the IntraLase 15 kHz femtosecond laser and Moria M2 microkeratomeJournal of Cataract & Refractive Surgery, 2008
- Double-Masked Comparison of Ketorolac Tromethamine 0.4% Versus Nepafenac Sodium 0.1% for Postoperative Healing Rates and Pain Control in Eyes Undergoing Surface AblationCornea, 2007
- Prospective Randomized Double-Masked Trial to Evaluate Perioperative Pain Profile in Different Stages of Simultaneous Bilateral LASIKCornea, 2006
- Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: A phase II, randomized, double-masked trialClinical Therapeutics, 2006
- LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatismOphthalmology, 2004
- Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patientsJournal of Cataract & Refractive Surgery, 2004
- Corneal flap complications in refractive surgeryJournal of Cataract & Refractive Surgery, 2003
- Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic UseDrug Safety, 2002
- Laser in situ keratomileusis for myopia and astigmatism: safety and efficacyOphthalmology, 2002
- Efficacy and safety of topical diclofenac in reducing ocular pain after excimer photorefractive keratectomyJournal of Cataract & Refractive Surgery, 1996